Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chuncui Jia"'
Autor:
Xi Qin, Maoqin Duan, Dening Pei, Jian Lin, Lan Wang, Peng Zhou, Wenrong Yao, Ying Guo, Xiang Li, Lei Tao, Youxue Ding, Lan Liu, Yong Zhou, Chuncui Jia, Chunming Rao, Junzhi Wang
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 12, Iss 2, Pp 308-316 (2022)
Recombinant human interferon α2b (rhIFNα2b) is widely used as an antiviral therapy agent for the treatment of hepatitis B and hepatitis C. The current identification test for rhIFNα2b is complex. In this study, an anti-rhIFNα2b nanobody was disco
Externí odkaz:
https://doaj.org/article/20a1c56ecc4f4d52a4c921558c992c94
Publikováno v:
Molecules, Vol 24, Iss 21, p 3845 (2019)
Soluble glycoprotein 130 kDa (sgp130)-Fc fusion protein, an innovative therapeutic bio-macromolecular drug specifically targeting IL-6 trans-signaling, proved to have good potential for application in the treatment of chronic inflammatory diseases. A
Externí odkaz:
https://doaj.org/article/21643d08346e4d4696f1b0241bcfa197
Publikováno v:
Molecules, Vol 24, Iss 7, p 1210 (2019)
During the past two decades, recombinant human interleukin-12 (rhIL-12) has emerged as one of the most potent cytokines in mediating antitumor activity in a variety of preclinical models and clinical studies. Purity is a critical quality attribute (C
Externí odkaz:
https://doaj.org/article/02488b2a864b4706ad993da0432859f8
Publikováno v:
Molecules, Vol 24, Iss 7, p 1210 (2019)
Molecules
Volume 24
Issue 7
Molecules
Volume 24
Issue 7
During the past two decades, recombinant human interleukin-12 (rhIL-12) has emerged as one of the most potent cytokines in mediating antitumor activity in a variety of preclinical models and clinical studies. Purity is a critical quality attribute (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73eca4048f3dd4dc753cf6e3a5f9f5c
https://www.mdpi.com/1420-3049/24/7/1210
https://www.mdpi.com/1420-3049/24/7/1210
Autor:
Qin Xi, Chuncui Jia, Wenrong Yao, Chunming Rao, Fang Huang, Li Shanhu, Yong Zhou, Lei Yu, You-Xue Ding, Shi Xinchang, Lan Liu, Junzhi Wang
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Bioassay of recombinant protein products is important tests to ensure protein effectiveness. Some recombinant protein products have no cells used in their bioassay but instead use animal models, while others have no suitable method. Here, we develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccfbf9ea0455de37279f0928aba564d
https://pubmed.ncbi.nlm.nih.gov/30846752
https://pubmed.ncbi.nlm.nih.gov/30846752
Publikováno v:
Molecules, Vol 24, Iss 21, p 3845 (2019)
Molecules
Volume 24
Issue 21
Molecules
Volume 24
Issue 21
Soluble glycoprotein 130 kDa (sgp130)-Fc fusion protein, an innovative therapeutic bio-macromolecular drug specifically targeting IL-6 trans-signaling, proved to have good potential for application in the treatment of chronic inflammatory diseases. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a872c1dec366dc224ea295095caca83b
https://doi.org/10.3390/molecules24213845
https://doi.org/10.3390/molecules24213845